Hester Biosciences バランスシートの健全性
財務の健全性 基準チェック /36
Hester Biosciencesの総株主資本は₹3.1B 、総負債は₹2.4Bで、負債比率は76.1%となります。総資産と総負債はそれぞれ₹6.7Bと₹3.6Bです。 Hester Biosciencesの EBIT は₹512.7Mで、利息カバレッジ比率6.9です。現金および短期投資は₹167.9Mです。
主要情報
76.1%
負債資本比率
₹2.39b
負債
| インタレスト・カバレッジ・レシオ | 6.9x |
| 現金 | ₹167.88m |
| エクイティ | ₹3.14b |
| 負債合計 | ₹3.55b |
| 総資産 | ₹6.69b |
財務の健全性に関する最新情報
These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Nov 25
These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Aug 25
Recent updates
Hester Biosciences Limited's (NSE:HESTERBIO) CEO Compensation Looks Acceptable To Us And Here's Why
Aug 23What Hester Biosciences Limited's (NSE:HESTERBIO) 26% Share Price Gain Is Not Telling You
Jul 27Revenues Working Against Hester Biosciences Limited's (NSE:HESTERBIO) Share Price
Jun 12Hester Biosciences (NSE:HESTERBIO) Has Announced A Dividend Of ₹10.00
Aug 01Would Hester Biosciences Limited (NSE:HESTERBIO) Be Valuable To Income Investors?
Mar 03Did You Miss Hester Biosciences' (NSE:HESTERBIO) Whopping 308% Share Price Gain?
Feb 13What Is The Ownership Structure Like For Hester Biosciences Limited (NSE:HESTERBIO)?
Jan 26Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Jan 11Hester Biosciences Limited's (NSE:HESTERBIO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 25Are Hester Biosciences's (NSE:HESTERBIO) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 10These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Nov 25How Does Hester Biosciences Limited (NSE:HESTERBIO) Fare As A Dividend Stock?
Nov 10If You Had Bought Hester Biosciences (NSE:HESTERBIO) Shares Five Years Ago You'd Have Earned 212% Returns
Oct 26What Type Of Shareholders Own The Most Number of Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Oct 05Are Strong Financial Prospects The Force That Is Driving The Momentum In Hester Biosciences Limited's NSE:HESTERBIO) Stock?
Sep 14These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Aug 25How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?
Aug 07Hester Biosciences Limited (NSE:HESTERBIO) Is Yielding 0.5% - But Is It A Buy?
Jul 07財務状況分析
短期負債: HESTERBIOの 短期資産 ( ₹2.2B ) が 短期負債 ( ₹1.3B ) を超えています。
長期負債: HESTERBIOの短期資産 ( ₹2.2B ) は 長期負債 ( ₹2.3B ) をカバーしていません。
デット・ツー・エクイティの歴史と分析
負債レベル: HESTERBIOの 純負債対資本比率 ( 70.7% ) は 高い と見なされます。
負債の削減: HESTERBIOの負債対資本比率は、過去 5 年間で56.6%から76.1%に増加しました。
債務返済能力: HESTERBIOの負債は 営業キャッシュフロー によって 十分にカバー されています ( 27.9% )。
インタレストカバレッジ: HESTERBIOの負債に対する 利息支払い は EBIT ( 6.9 x coverage) によって 十分にカバーされています。